Table 2

Programme losses (mortality and lost to follow-up (LTFU) in all adolescents and perinatally infected adolescents (9-19 years) compared with that of young adults (20-28 years)

Mortality

LTFU


Age group

Rates (per 100 PYS)

AHR*

p-value

Rates (per 100 PYS)

AHR*

p-value


All adolescents

1.2 (0.3-4.8)

0.56 (0.13-2.32)

0.42

7.2 (4.1-12.6)

0.74 (0.41-1.34)

0.33


Perinatally infected adolescents

0.8 (0.1-5.5)

0.39 (0.05-2.86)

0.35

3.9 (1.6-9.4)

0.39 (0.16-0.96)

0.04


Young adults (ref)

3.1 (2.4-3.9)

1.00

-

10.2 (9.0-11.7)

1.00

-


PYS person-years; UHR unadjusted hazard ratio; AHR adjusted hazard ratio

*adjusted for gender, baseline CD4, baseline viral load

Nglazi et al. BMC Infectious Diseases 2012 12:21   doi:10.1186/1471-2334-12-21

Open Data